Abstract

Insights

Routine surveillance detected oseltamivir resistance in 9 out of 326 influenza virus isolates. Monitoring antiviral resistance is crucial for controlling drug use and tracking spread in the population.

Area of Science:

  • Virology
  • Infectious Diseases
  • Public Health

Background:

  • Influenza virus resistance monitoring is a routine surveillance activity.
  • The National Reference Laboratory for Influenza and Non-Influenza Respiratory Viral Diseases (NRL/INI) conducts this monitoring.
  • The aim is to detect neuraminidase inhibitor (oseltamivir) resistance in influenza patients.

Purpose of the Study:

  • To detect oseltamivir resistance in influenza virus isolates.
  • To assess the prevalence of antiviral resistance in circulating influenza strains.

Main Methods:

  • 326 influenza virus isolates from 2013/2014 to 2019/2020 seasons were analyzed.
  • Virus isolation was performed using Madin-Darby canine kidney (MDCK) cells.
  • Oseltamivir resistance was tested using the NA-Star Influenza Neuraminidase Inhibitor Resistance Detection Kit.

Main Results:

  • Nine out of 326 (approximately 2.8%) influenza virus isolates were found to be oseltamivir resistant.
  • Resistant strains exhibited average IC50 values 100 times higher than sensitive strains.

Conclusions:

  • Influenza virus resistance monitoring is vital for guiding antiviral prescription and surveillance.
  • Monitoring is essential in both hospitalized and outpatient settings to detect emerging resistance.
  • Early detection of resistant strains aids in controlling antiviral drug resistance spread within the population.